WO2023249915A1 - Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds - Google Patents
Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds Download PDFInfo
- Publication number
- WO2023249915A1 WO2023249915A1 PCT/US2023/025681 US2023025681W WO2023249915A1 WO 2023249915 A1 WO2023249915 A1 WO 2023249915A1 US 2023025681 W US2023025681 W US 2023025681W WO 2023249915 A1 WO2023249915 A1 WO 2023249915A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl group
- branched
- formula
- linear
- chosen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present disclosure relates to cosmetic compositions comprising a combination of natural emulsifiers and compound of thiopyridlnone type.
- ridn care active Ingredients it is preferable for ridn care active Ingredients to be absorbed by the ridn or penetrated into the skin as much as possible.
- ridn absorption or ridn penetration of such ridn care active Ingredients Is not easy due to the barrier function of the skin.
- one possible approach to enhance the ridn penetration of a skin care active ingredient may be to use a skin penetration enhancer with the skin care active ingredient.
- the present disclosure relates to stable oil-in-water cosmetic compositions comprising compound of thiopyridinone type and a blend of natural emulsifiers.
- the cosmetic compositions have low viscosity.
- the compositions described in the instant disclosure are unique in comparison to other traditional oil-in-water compositions that contain emulsifiers containing PEG groups that offer the greatest flexibility and stability when formulating because of the oligomeric nature of the molecules.
- emulsifiers containing PEG groups that offer the greatest flexibility and stability when formulating because of the oligomeric nature of the molecules.
- natural-based emulsifiers are in far fewer number.
- they do not have the same advantages as the aforementioned oligomeric emulsifiers.
- Natural emulsifiers are often more difficult to formulate with, but they have benefits of naturality.
- the inventors have discovered that the inclusion of a combination of compound of thiopyridinone type (I) or (I') and a blend of natural emulsifiers surprisingly stabilize oil-in-water cosmetic compositions and in some cases would enhance the penetration of the compound of thioprydinone type.
- the oil-in-water cosmetic composition typically include: i) at least one compound selected from compounds of formula (I) and tautomer of formula (I') herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture:
- R 1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ;
- R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 - C 12 or cyclic C 3 -C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R 3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals; c) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals
- the oil-in-water cosmetic composition is physically stable.
- the oil-in-water composition might comprise one or more Polyglyceryl Fatty Acid Ester.
- the oil-in-water might comprise one or more oils.
- the compound i) is typically present in the cosmetic compositions in an amount of from about 0.01 to about 10 wt.%, based on the total weight of the cosmetic composition. In some cases, the amount of compound I) is present in an amount of from about 0.1 to about 5 wt.%, based on the total weight of the cosmetic composition. In some embodiments, the compound i) is typically present in the cosmetic compositions in an amount of from about 0.5 to about 3 wt.%, based on the total weight of the cosmetic composition.
- the cosmetic compositions may include a blend of at least two or more natural emulsifiers that have intermediate to high HLB. In some embodiments, the cosmetic compositions may include a blend of at least two or more natural emulsifiers that have a HLB from about 10 to about 15. In one or more embodiments, the at least two or more natural emulsifiers has a HLB from about 10 to about 15.
- the cosmetic composition may include at least two or more natural emulsifiers selected from the group consisting of inulin lauryl carbamate, C 1 2-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof.
- the at least two or more natural emulsifiers is inuline carbamate.
- the cosmetic composition may include one or more Polyglyceryl Fatty Acid Ester.
- the one or more Polyglyceryl Fatty Acid Ester have an HLB from about 8 to about 20.
- the polyglyceryl fatty acid esters has a polyglyceryl moiety derived from 2 to 10 glycerins, preferably 2 to 8 glycerins, and more preferably from 2 to 6 glycerins.
- the one or more polyglyceryl fatty acid ester Is chosen from polyglyceryl monolaurate comprising 2 to 6 glycerol units, polyglyceryl monocaprate comprising 2 to 6 glycerol units, polyglyceryl monooleate comprising 2 to 6 glycerol units, and polyglyceryl distearate comprising 2 to 6 glycerol units.
- the one or more polyglyceryl fatty acid esters is selected from the group consisting of polyglyceryl-4 caprate, polyglyceryl-6 dicaprate, polyglyceryl-6 dioleate, polyglyceryl-6 distearate, and mixtures thereof.
- the one or more polyglyceryl fatty acid esters is present from about 0.5 to about 3 wt.%, based on the total weight of the cosmetic composition.
- the composition provides enhanced penetration of the i) compound of thiopyridinone type in an in vitro penetration test.
- the at least two or more natural emulsifiers are present from about 0.3 to about 6 wt.%, based on the total weight of the cosmetic composition.
- the sucrose have an intermediate to high HLB.
- the i) compound of thiopyridinone type has a logP value ranging from about -1.5 to about 1.5.
- the cosmetic composition might comprise one or more oils.
- the cosmetic compositions may include non-natural emulsifiers.
- the cosmetic compositions may include one or more thickening polymers.
- the cosmetic compositions may include one or more fatty compounds.
- the cosmetic composition has a low viscosity.
- the cosmetic compositions may include inulin lauryl carbamate that can be present from about 0.2 wt.% to about 3 wt.%, based on the total weight of the cosmetic composition.
- the cosmetic composition may have a pH ranging from about 4.5 to about 6.5, preferably from about 5 to about 6.
- the cosmetic composition may include:
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ;
- R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 - C 12 or cyclic C 3 -C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals; c) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals
- R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; ii. about 0.5 to about 2 wt.% of at least two or more natural emulsifiers that are elected from the group consisting of inulin lauryl carbamate, C 12 -20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyi Alcohol (And) Behenyl Alcohol (And) Arachidyi Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof. wherein the weight percentages are
- the cosmetic compositions may include: i) from about 0.01 to about 10 wt.% of at least one compound selected from compounds of formula (I) and tautomer of formula (I') herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 1 0 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:
- R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1 -C12 or branched C3-C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1 -C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1 -C8 alkoxy radicals - R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1 -C10 or branched C3-C10 alkyl group;
- the cosmetic compositions can be used in a method that comprises applying the cosmetic compositions to the skin of humans.
- the cosmetic composition provides enhanced penetration of the compound of thiopyridinone type into skin.
- Another aspect of the instant disclosure is methods of increasing the percentage of the compound of thiopyridinone type deposited in skin, the method comprising topically applying the cosmetic composition of the instant disclosure to skin, wherein the cosmetic composition of the instant disclosure increases the percentage of the compound of thiopyridinone type deposited in the skin.
- FIG. 1 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Base Formula and Comparative Examples.
- FIG.2 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Inventive and Comparative Examples.
- FIG.3 is a graph showing the percentage of applied Niacinamide penetration for Base Formula and Comparative Examples.
- FIG.4 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Inventive and Comparative Examples.
- compositions typically including at least one compound corresponding to the following formula (I) or (I’), referred to as "compound of thiopyridinone type”.
- the present disclosure provides cosmetic compositions that are unique in comparison to conventional cosmetic compositions because they contain an association of compound of thiopyridinone type and a blend of natural emulsifiers, that show to be stable oil-in-water cosmetic compositions.
- compositions of the instant disclosure typically include: i) at least one compound selected from compounds of formula (I) and tautomer of formula (I’) herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ;
- R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 - C 12 or cyclic C 3 -C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R 3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C-i-C 8 alkoxy radicals; c) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals
- R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; ii) at least two or more natural emulsifiers; and wherein the oil cosmetic composition is physically stable.
- natural emulsifiers were able to effectively stabilize an o/w emulsion containing the newly developed raw material, compound of thiopyridinone type, with the same effectiveness as PEG-based emulsifiers.
- Cosmetic formulations comprising the novel association that are appropriate for topical application to the skin include compositions having low viscosity such as lotion, serum, gel, gel cream.
- natural refers to a compound or component that is obtained directly from the earth or soil or from plants or animals, via, if appropriate, one or more physical processes, such as grinding, refining, distillation, purification or filtration.
- a "natural emulsifier” could still be subjected to a synthetic process.
- 012-22 alkyl glucoside is not extracted from plants. It is made synthetically from 012-22 alcohols (which are extracted and separated from natural sources) and glucose (which is from natural sources). It is still considered completely “natural” because it is comprised of 100% natural components, even though the end result is made synthetically.
- the term "natural”, as used herein is defined as having more than 80% w/w naturally occurring elements in the raw material.
- the % naturality of RM is equal to molecular weight of naturally-occurring portions of molecule divided by total molecular weight of molecule.
- sucrose laurate there are two components to synthesis this raw material: sucrose and lauric acid.
- sucrose is 100% natural in that is extracted from sugar cane; thus 100% of carbons in the molecule are natural.
- the lauric acid is 100% natural because it is derived from coconut; thus 100% of carbons in the molecule are natural. Even though a synthetic process is preformed to make sucrose laurate, 100% of the carbons that comprise the molecule came from natural sources.
- Suitable components may be included or excluded from the formulations for the cosmetic compositions depending on the specific combination of other components, the form of the cosmetic compositions, and/or the use of the formulation (e.g., a lotion, a serum, gel, etc.).
- Compounds Of Thionvridinone Type may be included or excluded from the formulations for the cosmetic compositions depending on the specific combination of other components, the form of the cosmetic compositions, and/or the use of the formulation (e.g., a lotion, a serum, gel, etc.).
- a "saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 -C 12 ⁇ is equivalent to a “linear (C 1 -C 12 )alkyl or branched (C 3 -C 12 )alkyl group” which correspond to a saturated C 1 -C 12 linear or branched C 3 -C 12 hydrocarbon based group, and preferably C 1 -C 10 linear or C 3 -C 10 branched hydrocarbon based group, more preferably C 1 - C 3 linear or C 3 -C 6 branched hydrocarbon-based;
- the linear or branched groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl.
- the saturated linear or branched alkyl groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl and octyl, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl.
- a saturated hydrocarbonated cyclic C 3 -C 8 group is a mono or bicyclic cycloalkyl group containing from 3 to 8 carbon atoms especially is a monocyclic cycloalkyl group in C5 to C7 such as cyclohexyl group, an "alkoxy radical" is an alkyl-oxy radical for which the alkyl radical is a linear or branched C 1 -C 16 and preferentially C 1 -C 8 hydrocarbon-based radical;
- an "aryl” group represents a fused or non-fused monocyclic or bicyclic carbon- based group comprising from 5 to 12 carbon atoms, preferably from 6 to 10 carbon atoms, and in which at least one ring is aromatic; preferentially, the aryl radical is a phenyl, biphenyl, naphthyl, more preferably a phenyl group ;
- salts of the compounds of formula (I), (I'), (II) or (II’) as defined herein after comprise the conventional non-toxic salts of said compounds, such as those formed from organic or inorganic acid or from organic or inorganic base.
- salts of the compounds of formula (I), (I’), (II) or (II') mention may be made of : the salts obtained by addition of the compound of formula (I) or (II) to : a mineral base, such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example; or an organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
- a mineral base such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example
- organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
- This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and/or oxygen atoms and may thus comprise, for example, one or more alcohol functions; mention may be made in particular of 2-amino-2-methylpropanol, ethanolamine, triethanolamine, 2-dimethylaminopropanol, 2-amino-2-(hydroxymethyl)-1,3-propanediol and 3- (dimethylamino)propylamine.
- salts of amino acids for instance lysine, arginine, guanidine, glutamic acid and aspartic acid.
- the salts of the compounds of formula (I) or (II) may be chosen from alkali metal or alkaline-earth metal salts such as sodium, potassium, calcium or magnesium salts and ammonium salts.
- organic or inorganic acid salt is more particularly chosen from salts chosen from a salt derived from i) hydrochloric acid HCI, ii) hydrobromic acid HBr, iii) sulfuric acid -H 2 SO 4 iv) alkylsulfonic acids: Alk-S(O) 2 OH such as methanesulfonic acid and ethanesulfonic acid; v) arylsulfonic acids: Ar-S(O) 2 OH such as benzenesulfonic acid and toluenesulfonic acid; vi) citric acid; vii) succinic acid; viii) tartaric acid; ix) lactic acid; x) alkoxysulfinic acids: Alk-0-S(0)OH such as methoxysulfinic acid and ethoxysulfinic acid; xi) aryloxysulfinic acids such as tolueneoxysulfinic acid and phenoxysul
- the acceptable solvates of the compounds described in the instant disclosure comprise conventional solvates such as those formed during the preparation of said compounds owing to the presence of solvents. Mention may be made, by way of example, of the solvates due to the presence of water or of linear or branched alcohols, such as ethanol or isopropanol.
- optical isomers are in particular, the enantiomers and the diastereoisomers.
- the compounds used according to the instant disclosure therefore correspond to formula (I) or tautomer (I') below or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture.
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -0-R 3 ii) -S-R 3 ;
- R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 -C 12 or cyclic C 3 - C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R 3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals; c
- the compound (I') is the tautomer form of the compound (I) when a tautomeric equilibrium exists according to the following scheme:
- R 1 represents one hydrogen atom.
- R1 represents a linear (C 1 -C 10 )alkyl group or branched (C 3 -C 10 )alkyl group, especially a linear (C 1 -C 3 )alkyl group or branched (C 3 -C 3 )alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl.
- the said alkyl group of R 1 is not substituted.
- R 2 represents one hydrogen atom.
- R 2 represents a linear (C 1 -C 10 )alkyl group or branched (C 3 -C 10 )alkyl group, especially a linear (C 1 -C 3 )alkyl group or branched (C 3 -C 6 )alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group ; the said alkyl group of R 2 being not substituted.
- R 2 represents a linear (C 1 -C 10 )alkyl group or branched (C 3 -C 10 )alkyl group, especially a linear (C 1 -C 6 )alkyl group or branched (C 3 -C 6 )alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i), ii), iii) and iv) as defined herein before.
- the said alkyl group being substituted by one or two groups selected from I), ii) and iii), more preferably by one or two groups selected from i) and iii), better substituted by one group iii) as carboxy.
- radical R 2 Another variant for radical R 2 is that the said alkyl group being substituted by one group iv) especially substituted by one phenyl group.
- R 2 represents a (C 3 -C 8 )cycloalkyl group, preferably a (C 5 -C 7 )cycloalkyl group such cyclohexyl.
- R 2 represents C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals, preferably a phenyl group particularly not substituted.
- R 3 represents a hydrogen atom.
- R 3 represents a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; particularly a linear (C 1 -C 3 )alkyl group or a branched (C 3 -C 6 )alkyl group, preferably (C 1 -C 4 )alkyl group such as methyl group.
- the compounds of formula (I) and tautomer (I') or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
- Ri denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 6 or branched C 3 -C 3 alkyl group optionally substituted with one or more groups, which may be Identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ; preferably optionally substituted with one or more groups i)
- R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 10 or branched C 3 -C 10 or cyclic C 3 - C 8 such as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -SR- 3 iii) -C(O)-O-R 3 ; iv) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 4 alkoxy radicals such as methoxy ; preferably substituted with one or more groups selected from I) and iii), preferably iii) such as carboxy
- R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 3 or branched C 3 -C 3 alkyl group
- the compounds
- R 1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 4 or branched C 3 -C 4 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from i) -OR 3 .
- R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 10 or branched C 3 -C 10 or cyclic C 3 -C 8 as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 iii) -C(O)-O-R 3 ; iv) a C5-C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 4 alkoxy radicals; R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 4 or branched C 3 -C 4 alkyl group such as methyl or ethyl .
- the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
- R 1 is a hydrogen atom
- R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 5 or branched C 3 -C 5 or cyclic C 3 - C 8 as C5 -C6 , substituted with one or more groups, which may be identical or different, chosen from v) -C(O)-O-R3, preferably substituted with one group iii) -C(O)-O-R 3 ; R 2 is even more preferably a saturated hydrocarbonated group linear C 1 -C 4 or branched C 3 -C 4 substituted with one group iii) -C(O)-OR 3 .
- compounds of formula (I) and tautomer are selected among compounds of formula (II) and also the tautomers thereof, the salts thereof, the solvates thereof and the optical isomers thereof, and the racemates thereof, alone or as a mixture :
- R1 and R3 have the same meaning than for compounds of formula (I) and (I') and X denotes an alkylene radical -(CH 2 ) n - with n being an integer ranging inclusively from 1 to 10, preferably ranging from 1 to 6, more preferably ranging from 1 to 4, such as 1, preferably R 3 represents a hydrogen atom.
- the following compounds are preferably used and their tautomer or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture:
- the compound according to the instant disclosure is the following:
- composition used according to the disclosure comprises at least one compound of formulae (I) and/or (II) as described above, in a physiologically acceptable medium.
- the compound (I), (I'), (II) and/or (IP) may be present in the composition used according to the disclosure in an amount which may be between 0.01% and 10% by weight, preferably between 0.1% and 5% by weight, in particular from 0.5% to 3% by weight, relative to the total weight of the composition.
- the natural emulsifiers may be chosen from: Inulin Lauryl Carbamate, C 1 2-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Cetearyl wheat straw glycosides and Cetearyl alcohol, Sorbitan Olivate, Glyceryl citrate stearate, Cetearyl Olivate (and) Sorbitan Olivate, other sucrose and glucose esters and ethers, amino acid-based emulsifiers, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof.
- Suitable hydrophobically-modifled natural emulsifiers include, for example, inulin lauryl carbamate, commercially available from Beneo Orafti under the tradename Inutec SP1.
- Suitable natural emulsifiers with an HLB around about 10 include, but are not limited to, polyglycerides and mixture thereof.
- the fatty add esters of a sugar that can be used as non ionic amphiphilic lipids can be chosen in particular from the group comprising esters or mixtures of esters of a C8-C22 fatty acid and of sucrose, of maltose, of glucose or of fructose, and esters or mixtures of esters of a C 1 4-C22 fatty acid and of methylglucose.
- the C8-C22 or C 1 4- C22 fatty acids forming the fatty unit of the esters that can be used in the emulsion comprise a saturated or unsaturated linear alkyl chain having, respectively, from 8 to 22 or from 14 to 22 carbon atoms.
- the fatty unit of the esters can be chosen in particular from stearates, behenates, arachidonates, palmitates, myristates, laurates, caprates and mixtures thereof.
- esters or of mixtures of esters of a fatty acid and of sucrose, of maltose, of glucose or of fructose mention may be made of sucrose monostearte, sucrose distearate, sucrose tristearate and mixtures thereof, such as the products sold by the company Croda under the name Crodesta F50, F70, F1 10 and F160 having, respectively, an HLB (Hydrophilic Lipophilic Balance) of 5, 7, 1 1 and 16; and, by way of example of esters or of mixtures of esters of a fatty acid and of methylglucose, mention may be made of the disearate of methylglucose and of polyglycerol-3, sold by the company Goldschmidt under the name Tego-care 450. Mention may also be made of glucose monoesters or maltose monoesters, such as methyl O-hexadecanoyl-6-D-glucoside and O-hexadecanoyl-6-D
- the fatty alcohol ethers of a sugar that can be used as nonionic amphiphilic lipids can be chosen in particular form the group comprising ethers or mixtures of ethers of a 08-022 fatty alcohol and of glucose, of maltose, of sucrose or of fructose, and ethers or mixtures of ethers of a C 4-C22 fatty alcohol and of methylglucose. They are in particular alkylpolyglucosides.
- the C8-C22 or C 1 4-C22 fatty alcohols forming the fatty unit of the ethers that can be used in the emulsion of the instant disclosure comprise a saturated or unsaturated linear alkyl chain having, respectively, from 8 to 22 or from 14 to 22 carbon atoms.
- the fatty unit of the ethers can be chosen in particular from decyl, cetyl, behenyl, arachidyl, stearyl, palmityl, myristyl, lauryl, capryl and hexadecanoyl units, and mixtures thereof such as cetearyL
- alkylpolyglucosides such as decylglucoside and laurylglucoside sold, for example, by the company Henkel under the respective names Plantaren 2000 and Plantaren 1200, cetostearylglucoside, optionally as a mixture with cetostearyl alcohol, sold, for example, under the name Montanov 68 by the company Seppic, under the name Tego-care CG90 by the company.
- Use is more particularly made, as nonionic amphiphilic lipid of this type, of sucrose monostearate, sucrose distearate, sucrose tristearate and mixtures thereof, the distearate of methylglucose and of polyglycerol-3, and alkylpolyglucosides.
- the natural emulsifiers having an HLB from around about 10 to about 15 will typically be employed in an amount of from about 0.5 to about 8 wt%, based on the total weight of the composition.
- the total amount of natural emulsifier present in the compositions is typically in an amount of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0 wt.% to about 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6, 5.8, 6.0, 6.2, 6.4, 6.6, 6.8, 7.0, 7.5 or 8.0 wt.%, based on the total weight of the composition.
- the natural emulsifiers may be chosen from one or more polyglyceryl fatty acid ester having an HLB value of 8.0 or more, preferably 8.5 or more, and more preferably 9.0 or more.
- a single type of polyglyceryl fatty acid ester may be used, but two or more different types of first polyglyceryl fatty acid ester may be used in combination.
- the one or more polyglyceryl fatty acid ester may have an HLB value of from 8.0 to 20.0, preferably from 8.5 to 18, and more preferably from 9.0 to 14.0.
- HLB hydrophilic-lipophilic balance
- the one or more polyglyceryl fatty acid ester may be chosen from mono, di, tri and more esters of saturated or unsaturated fatty acid(s).
- the one or more polyglyceryl fatty acid ester comprises 2 to 4 glycerol units, preferably 3 or 4 glycerol units, and more preferably 4 glycerol units.
- the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 12 or fewer carbon atoms, preferably 11 or fewer carbon atoms, and more preferably 10 or fewer carbon atoms.
- the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 4 or more carbon atoms, preferably 6 or more carbon atoms, and more preferably 8 or more carbon atoms.
- the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may have carbon atoms of from 4 to 12, preferably from 6 to 11, and more preferably from 8 to 10 carbon atoms.
- the fatty acid for the fatty acid moiety of the one or more polyglyceryl fatty acid ester may be saturated or unsaturated, and may be selected from caprylic acid, capric acid, and lauric acid.
- the one or more polyglyceryl fatty acid ester(s) may be selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), PG5 myristate (HLB: 15.4), PG5 stearate (HLB: 15), PG-5 oleate (HLB 11.5), PG6 caprylate (HLB: 14.6), PG6 caprate (HLB: 13.1), PG6 laurate (HLB: 14.1), PG10 laurate (HLB: 15.2), PG10 myristate (HLB: 14.9), PG10 stearate (HLB: 14.1), PG10 isostearate (HLB: 13.7), PG-10 diisostearate (HLB: 11), PG10 oleate (HLB: 13.0), PG10 cocoate (HLB: 16), and mixtures thereof.
- the one or more polyglyceryl fatty add ester(s) be selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), and mixtures thereof.
- the one or more polyglyceryl fatty add ester may be chosen from mono, di, tri and more esters of saturated or unsaturated fatty acid(s).
- the fatty add for the fatty add moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 14 or more carbon atoms, preferably 16 or more carbon atoms, and more preferably 18 or more carbon atoms.
- the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty add ester may comprise 30 or fewer carbon atoms, preferably 24 or fewer carbon atoms, and more preferably 20 or fewer carbon atoms.
- the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may have from 14 to 30, preferably from 16 to 24, and more preferably from 18 to 20 carbon atoms.
- the fatty acid for the fatty acid moiety of the one or more polyglyceryl fatty acid ester may be saturated or unsaturated, and may be selected from myristic acid, stearic acid, isostearic acid, and oleic acid.
- the one or more polyglyceryl fatty acid ester(s) may be selected from the group consisting of PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), PG6 distearate (HLB: 8), PG10 distearate (HLB: about 9), PG10 tristearate (HLB: 8), PG10 diisostearate (HLB: 10), PG10 triisostearate (HLB: 8), PG10 tricocoate (HLB: 9), and mixtures thereof.
- PG2 sesquicaprylate HLB: about 8
- PG2 caprate HLB: 9.5
- PG2 laurate
- the one or more polyglyceryl fatty acid be selected from the group consisting of PG2 isostearate (HUB: 8), PG2 oleate (HLB: 8), PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), and mixtures thereof.
- the one or more polyglyceryl fatty acid ester mention may be made of Sunsoft® Q-17D(G) from Taiyo Kagaku Co., Ltd., Sunsoft® A-121 E-C from Taiyo Kagaku Co., Ltd., and Tegosoft® PC 41 from Evonik Co., Ltd.
- the amount of the one or more polyglyceryl fatty acid ester(s) in the composition according to the Instant disclosure may be from about 0.5 to about 3 wt.% based on the total weight of the cosmetic composition.
- the total the one or more polyglyceryl fatty acid esters) in the composition is typically in an amount of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0 wt.% to about 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6, 5.8, 6.0, 6.2, 6.4, 6.6, 6.8, 7.0, 7.5 or 8.0 wt.%, based on the total weight of the composition.
- a log P value is a value for the base-ten logarithm of the apparent octan-1- ol/water partition coefficient.
- the log p values are known and are determined by a standard test which determines the concentration of the (c) compound in octan-1-ol and water.
- the log P may be calculated according to the method described in the article by Meylan and Howard: Atom/Fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci., 84: 83-92, 1995. This value may also be calculated using numerous commercially available software packages, which determine the log P as a function of the structure of a molecule. By way of example, mention may be made of the Epiwin software from the United States Environmental Agency.
- the values may especially be calculated using the ACD (Advanced Chemistry Development) Solaris software V4.67; they may also be obtained from Exploring QSAR: hydrophobic, electronic and steric constants (ACS professional reference book, 1995). There is also an Internet site which provides estimated values (address: http://esc.syrres.com/interkow/kowdemo.htm).
- composition may also include Vitamin B3 and derivatives.
- Vitamin B3 also called vitamin PR, is a compound of the following formula: in which R may be -CONH2 (niacinamide), -COOK (nicotinic acid or niacin), or CH2OH (nicotinyl alcohol), -CO-NH-CH2-COOH (nicotinuric acid) or -CO-NH-OH (niconityl).
- the cosmetic compositions include an oil phase comprising one or more oils.
- the amount of oil phase e.g., the total amount of oils
- the cosmetic composition includes oils that are plant based or vegetable based oils.
- the amount of oils present in the cosmetic composition may be from about 0.5 to about 40 wt%, about 0.5 to about 38 wt%, about 0.5 to about 34 wt.%, about 0.5 to about 32 wt.%; 0.5 to about 30 wt.%, 0.5 to about 28 wt.%, 0.5 to about 26 wt.%, 0.5 to about 24 wt.%, about 1 to about 40 wt.%, 1 to about 38 wt.%, 1 to about 36 wt.%, 1 to about 34 wt.%, 1 to about 32 wt.%, 1 to about 30 wt.%, 1 to about 28 wt.%, 1 to about 26 wt.%, 1 to about 24 wt.%, about 2 to about 40 wt.%, 2 to about 38 wt.%, 2 to about 36 wt.%, 2 to about 34 wt%, 2 to about 32 wt.%, 2 to about 30 wt.%, 2
- the cosmetic composition may exclude synthetic oils.
- the cosmetic composition may exclude oils other than plant based and vegetable based oils.
- the amount of synthetic oils and/or oils other than plant based and vegetable based oil may be about 5 wt.% or less, about 4 wt.% or less, about 3 wt.% or less, about 2 wt.% or less, about 1 wt.% or less, or about 0.5 wt.% or less, based on the total weight of the cosmetic composition.
- the cosmetic composition is free of or essentially free of synthetic oils and/or oils other than plant based and vegetable based oil.
- oil means any fatty substance which is in liquid form at room temperature (20-25°C.) and at atmospheric pressure (760 mmHg). Often, at least one of the oils in the cosmetic composition is part of an oily phase.
- An "oily phase” is a phase comprising at least one oil that may include additional liposoluble and lipophilic ingredients and the fatty substances. Oil that is suitable for use herein may be volatile or non-volatile.
- volatile oil relates to an oil that is capable of evaporating on contact with the skin or a keratin fiber in less than one hour, at room temperature and atmospheric pressure.
- Volatile oil(s) are liquid at room temperature and have a nonzero vapor pressure, at room temperature and atmospheric pressure, ranging in particular from 0.13 Pa to 40 000 Pa (10-3 to 300 mmHg).
- non-volatile oil relates to an oil that remains on the skin or the keratin fiber, at room temperature and atmospheric pressure, for at least several hours and which in particular has a vapor pressure of less than 10-3 mmHg (0.13 Pa).
- composition according to the present invention may comprise at least one pH adjusting agent (pH adjuster). Two or more pH adjusting agents may be used in combination. Thus, a single type of pH adjusting agent or a combination of different types of pH adjusting agents may be used.
- At least one acidifying agent and/or at least one basifying agent may be used.
- the acidifying agent may be a monovalent or polyvalent, such as divalent, acid.
- the acidifying agents can be, for example, mineral (inorganic) acids such as hydrochloric acid, sulfuric acid, phosphoric acid, or organic acids such as carboxylic acids, for instance tartaric acid, citric acid, and lactic acid, as well as sulphonic acids.
- mineral (inorganic) acids such as hydrochloric acid, sulfuric acid, phosphoric acid
- organic acids such as carboxylic acids, for instance tartaric acid, citric acid, and lactic acid, as well as sulphonic acids.
- the basifying agent may be a monovalent or polyvalent, such as divalent, base.
- the basifying agents may be mineral (inorganic) or organic, or hybrid.
- the mineral basifying agents may be chosen from aqueous ammonia; alkali metal carbonates or bicarbonates such as sodium or potassium carbonates and sodium or potassium bicarbonates; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; and mixtures thereof.
- the organic basifying agents may be chosen from organic amines with a pKb at 25°C of less than 12, preferably less than 10, and even more advantageously less than 6. It should be noted that it is the pKb corresponding to the function of highest basicity.
- the organic amines do not comprise any alkyl or alkenyl fatty chains comprising more than ten carbon atoms.
- the organic basifying agent may be chosen, for example, from akanolamines, oxyethylenated and/or oxypropylenated ethylenediamines, amino acids and amine compounds of formula (III) below: in which
- W represents a C 1 -C 6 divalent alkylene radical optionally substituted with one or more hydroxyl groups or a C 1 -C 8 alkyl radical, and optionally interrupted with one or more heteroatoms such as O and N, and
- R x , R y , R z , and Rt which may be identical or different, represent a hydrogen atom or a C 1 -C 3 alkyl, C 1 -C 3 hydroxyalkyl, or C 1 -C 3 aminoalkyl radical.
- Examples of the amine compounds of formula (III) that may be mentioned include 1,3- diaminopropane, 1 ,3-diamino-2-propanol, spermine and spermidine.
- alkanolamine means an organic amine comprising a primary, secondary or tertiary amine function, and one or more linear or branched C 1 -C 8 alkyl groups bearing one or more hydroxyl radicals.
- Alkanolamines such as monoalkanolamines, dialkanolamines or trialkanolamines comprising one to three identical or different C 1 -C 4 hydroxyalkyl radicals may be suitable for the present invention.
- monoethanolamine MEA
- diethanolamine triethanolamine
- monoisopropanolamine diisopropanolamine
- diisopropanolamine N-dimethylaminoethanolamine
- 2-amino- 2-methyl-1 -propanol triisopropanolamine
- 2-amino-2-methyl-1,3-propanediol 3-amino- 1 ,2-propanediol, 3-dimethylamino-1,2-propanediol and tris(hydroxymethylamino)methane.
- Amino acids that may be used are of natural or synthetic origin, in their L, D or racemic form, and comprise at least one acid function chosen more particularly from carboxylic acid, sulfonic acid, phosphonic acid or phosphoric acid functions.
- the amino acids may be in neutral or ionic form.
- amino acids that may be used in the present invention, mention may be made especially of aspartic acid, glutamic acid, alanine, arginine, ornithine, citrulline, asparagine, carnitine, cysteine, glutamine, glycine, histidine, lysine, isoleuclne, leucine, methionine, N-phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine and valine.
- amino acids are basic amino acids comprising an additional amine function optionally included in a ring or in an ureido function.
- Such basic amino acids may preferably be chosen from those corresponding to formula (IV) below: in which
- R represents a group chosen from:
- the compounds corresponding to formula (IV) include histidine, lysine, arginine, ornithine and citrulline.
- the organic basifying agent may be chosen from organic amines of heterocyclic type. Besides histidine that has already been mentioned in the amino adds, mention may in particular be made of pyridine, piperidine, imidazole, triazole, tetrazole and benzimidazole.
- the organic basifying agent may also be chosen from amino acid dipeptides.
- amino acid dipeptides that may be used in the present invention, mention may be made especially of camosine, anserine and baleine.
- the organic basifying agent may also be chosen from compounds comprising a guanidine function.
- amines of this type that may be used in the present invention, besides arginine, which has already been mentioned as an amino acid, mention may be made especially of creatine, creatinine, 1,1-dimethylguanidine, 1,1-diethyl-guanidine, glycocyamine, metformin, agmatine, N-amidinoalanine, 3-guanidino-propionic acid, 4- guanidinobutyric acid and 2-([amino(imino)methyl]amino)ethane-1 -sulfonic acid.
- the organic basifying agent may be selected from amino acids, preferably basic amino acids, and more preferably arginine, lysine, histidine or mixtures thereof. Even more preferentially, the organic basifying agent may be arginine.
- Hybrid compounds that may be mentioned include the salts of the amines mentioned previously with acids such as carbonic acid or hydrochloric acid. Guanidine carbonate or monoethanolamine hydrochloride may be used in particular.
- the pH adjusting agent may be present in an amount of 0.01 % by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, relative to the total weight of the composition.
- the pH adjusting agent may be present in an amount of 15% by weight or less, preferably 10% by weight or less, and more preferably 5% by weight or less, relative to the total weight of the composition.
- the pH adjusting agent may be present in an amount ranging from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight, and more preferably from 0.1% to 5% by weight or less, relative to the total weight of the composition.
- composition according to the present invention have a pH of 4.5 or more, and more preferably 5 or more.
- composition according to the present invention have a pH of 6.5 or less, and more preferably 6 or less.
- composition according to the present invention have a pH of from 4.5 to 6.5, and more preferably from 5 to 6.
- the pH of the composition means the pH of the aqueous phase of the composition according to the present invention.
- At least one buffer or buffering agent also be used, as the pH adjusting agent, in combination with the acidifying agent and/or the basifying agent, in order to stabilize the pH of the composition according to the present invention.
- any of commonly known buffers may be used.
- salts of acids or bases preferably salts of weak acids or weak bases, may be used.
- sodium citrate or sodium lactate may be used as the buffer, if citric acid or lactic acid is used as the acidifying agent.
- the cosmetic compositions include a cosmetically acceptable carrier system.
- cosmetically acceptable means a earner that is compatible with any keratinous substrate, and for purposes hereof, includes water and optionally water based solvents subject to any exclusions as disclosed herein.
- the cosmetic compositions may comprise any constituent normally employed in the topical application and administration envisaged. Mention may in particular be made of water, solvents, fatty compounds (i.e. described by the International Federation Societies of Cosmetic Chemists, for example, in Cosmetic Raw Material Analysis and Quality, Volume I: Hydrocarbons, Glycerides, Waxes and Other Esters (Redwood Books, 1994), which is incorporated herein by reference in its entirety), polyols, pigments, fillers, silicones, surfactants, thickeners, gelling agents, preservatives and their mixtures in all proportions.
- fatty compounds i.e. described by the International Federation Societies of Cosmetic Chemists, for example, in Cosmetic Raw Material Analysis and Quality, Volume I: Hydrocarbons, Glycerides, Waxes and Other Esters (Redwood Books, 1994), which is incorporated herein by reference in its entirety
- polyols pigments
- fillers silicones
- surfactants thickeners
- gelling agents preservatives and their mixtures
- the composition may be in the form of macroemulsion.
- Macroemulsions are dispersed liquid-liquid, thermodynamically unstable systems with particle sizes ranging from 1 to 100 pm (orders of magnitude), which, most often, do not form spontaneously. Macroemulsions scatter light effectively and therefore appear milky, because their droplets are greater than a wavelength of light.[1] They are part of a larger family of emulsions along with miniemulsions (or nanoemulsions). As with all emulsions, one phase serves as the dispersing agent. It is often called the continuous or outer phase.
- the remaining phase(s) are disperse or inner phase(s), because the liquid droplets are finely distributed amongst the larger continuous phase droplets.
- This type of emulsion is thermodynamically unstable, but can be stabilized for a period of time with applications of kinetic energy.
- Surfactants as the main emulsifiers
- Emulsions can be stabilized otherwise with polymers, solid particles (Pickering emulsions) or proteins.
- the macroemulsion may have a dispersed phase with a particle size of no less than 600 nm total as minimum of range. Most likely in micron range, such as 0.8 to 20 microns. They do not form spontaneously (like microemulsions do).
- the OA/V architecture or structure which consists of oil phases dispersed in an aqueous phase, has an external aqueous phase, and therefore if the composition according to the Instant disclosure has the O/W architecture or structure, it can provide a pleasant feeling during use because of the feeling of immediate freshness that the aqueous phase can provide.
- the particle size can be measured by a dynamic light scattering method.
- the particle size measurement can be performed by, for example, the Particle Size Analyzer ELSZ-2000 series, marketed by Otsuka Electronics Co., Ltd.
- the particle size can be a volume-average particle diameter or a numberaverage particle diameter, preferably a volume-average particle diameter.
- the instant disclosure also relates to methods of using the cosmetic compositions described herein.
- the cosmetic compositions can be used in a method that comprises applying the cosmetic compositions to the skin of humans. In some cases, the composition is applied to the face.
- the cosmetic composition can be used in methods for depigmenting and/or bleaching keratin materials, preferably skin, comprising the step of: applying to the keratin substance the composition according to the compositions described herein. The aforementioned methods are non-therapeutic.
- the instant disclosure also relates to non-therapeutic cosmetic process for depigmenting, lightening and/or bleaching keratin materials, preferably skin, comprising the step of applying to the keratin substance the composition according to the compositions described herein.
- the cosmetic composition may be applied once per day, twice per day, or more than once or twice per day. In some cases, the composition is applied in the evenings before bed. In other cases, the compositions are applied in the morning. In still other cases, the composition may be applied immediately after washing the skin.
- the compositions may be used once, or for a series of days, weeks, or months. For example, the compositions may be used daily for a period of 1 , 2, 3, 4, 5, 6, 7, 8 or more weeks, or months.
- Another aspect of the instant disclosure relates to a use of: a. One or more Polyglyceryl Fatty Acid Ester; for enhancing or improving the skin penetration of b. Compound of thlopyridinone type; in a composition in the form of a macroemulsion comprising: c. One or more oils.
- Compound 20 is synthesized as disclosed in example 2 of patent EP3390363.
- compositions were prepared using the following general procedure:
- the water soluble raw materials (minus actives) were added to the main kettle and dissolved. Polymers were then added and mixed until well-dispersed. Batch was heated to 75C. In a side kettle, the fatty compounds, silicones, and emulsifiers/surfactants were mixed together and heated to 75C. The side kettle was added to the main kettle while homogenizing well. When well emulsified, the batch was cooled to room temperature, and actives and fillers were added.
- inventive Examples and Comparative Examples were tested for stability.
- the stability of the inventive and comparative Examples was assessed by following the procedure described below.
- 1 means the emulsion is stable and homogenous during and soon after processing, and is also stable after at least 2 months at 25’C and 45°C.
- 2 could be anything from product being not homogenous in texture to after formulation to noticeable separation of phases after 2 weeks at 25°C and/or 45°C
- THP stable, direct emulsions containing THP, using natural emulsifiers, rather than PEG-containing emulsifiers, which are mainly synthetic emulsifiers.
- natural emulsifiers rather than PEG-containing emulsifiers, which are mainly synthetic emulsifiers.
- THP could be included into a physically stable high viscosity emulsion containing more than 15% of fatty acids.
- having a slightly lower viscosity emulsion would allow for many more architectures with vastly different sensorial attrfoutes. Thinner creams, lotions, and serums containing THP could be developed with natural emulsifiers, while remaining stable and sensorial.
- compositions were prepared using the general procedure described above.
- Inventive Examples and Comparative Examples were tested to measure the enhanced penetration of the active ingredients.
- the enhanced penetration of the inventive and comparative Examples was assessed by following the procedure described below.
- the penetration test experiments were performed in a Franz diffusion cell (Hanson) with a Strat-M membrane (Millipore, diameter of 15 mm).
- This equipment was composed of a donor part and a receptor part with the Strat-M membrane between the donor and receptor parts.
- the receptor part with a predetermined volume was filled with a receiving solution (0.25 wt.% Tween 80/deionized water) maintained at a temperature of 32 °C, which was continuously stirred with a small magnetic bar.
- a receiving solution (0.25 wt.% Tween 80/deionized water) maintained at a temperature of 32 °C, which was continuously stirred with a small magnetic bar.
- Each of the compositions according to Examples 3-5 and Comparative Examples 3-6 was spread with a spatula on the membrane of the donor part with an amount of 30 mg/cm2.
- the receiving solution was withdrawn from the receptor part, while providing the same amount of a new receiving solution to the receptor part to maintain the same penetration conditions.
- the withdrawn receiving solution was analyzed by HPLC to determine the amount of the active ingredient in the receiving solution.
- the percentage of the active ingredient that passed through the membrane was calculated by dividing the detected amount of the active ingredient in the receiving solution by the amount of the active ingredient spread on the membrane.
- the amount of active in the cell was then plotted over time to determine the speed of diffusion through the membrane, as well as the total amount diffused after 24 hrs.
- penetration enhancers were studied (i.e. Ethoxydiglycol, Dimethyl isosorbide, Sodium dilauramidoglutamide lysine as well as other raw materials that are not knowns to be penetration enhancers (i.e. Laureth-4 and polyglyceryl-4 caprate).
- Figure 1 and Figure 2 represented the percentage of the penetration of the thiopyridinone compound (i.e. THP) through the membrane over time.
- the Base Formula started to penetrate through the membrane within the hour and kept increasing overtime up to a plateau after 24 hours.
- the base formula did not contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
- Comp. Ex. 3 and Comp. Ex. 4. showed that the penetration of the THP was slow as well at the beginning. In the case of Comp. Ex. 4, it was even observed that the penetration of the thiopyridinone compound was very limited over time. In the case of Comp. Ex. 3, the penetration increased slowly and reached a plateau as well, but still the penetration didn't reach the high level reached with the base formula. Both Comparative Example didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
- Comp. Ex. 6 showed a similar pattern as Comp. Ex. 4.
- the penetration of the thiopyridinone compound was slow and very limited. In the case of Comp. Ex. 5, the penetration was higher at the beginning, then reached a plateau.
- Both Comparative Example didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
- the Inventive Ex. 3 demonstrated that the penetration of the thiopyridinone compound was at about 78% at the beginning which was much higher than any of the Comp. Ex. Then, the penetration kept increasing and was above 80% after only few hours. The level of penetration was stable over 24 hours.
- the inventive example proved that the presence of a Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20 not only increased the level of penetration of the active, but surprisingly, make it happened almost immediately after application of the products on the membrane.
- Figure 3 and Figure 4 represented the percentage of the penetration of Niacinamide through the membrane overtime.
- the Base Formula started to penetrate through the membrane within the hour and kept increasing over time up to a plateau after 24 hours.
- the base formula did not contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
- Comp. Ex. 6 showed a similar pattern as Comp. Ex. 4.
- the penetration of the niacinamide was slow and very limited. In the case of Comp. Ex. 5, the penetration was higher at the beginning, then reached a plateau.
- All Comparative Examples didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
- the Inventive Ex. 4 demonstrated that the penetration of niacinamide was at about 78% at the beginning which was much higher than any of the Comp. Ex. Then, the penetration kept increasing and was above 80% after only few hours. The level of penetration was stable over 24 hours.
- the inventive example proved that the presence of a Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20 not only increased the level of penetration of the active, but surprisingly, make it happened almost immediately after application of the products on the membrane.
- At least one means one or more and thus includes individual components as well as mixtures/combinations.
- free and “devoid” indicates that no reliably measurable excluded material is present in the composition, typically 0% by weight, based on the total weight of the composition.
- essentially free means that, while it prefers that no excluded material is present in the composition, it is possible to have very small amounts of the excluded material in the composition of the disclosure, provided that these amounts do not materially affect the advantageous properties of the canposition.
- essentially free means that excluded material can be present in the composition at an amount of less than about 0.1% by weight, based on the total weight of the composition.
- weight percent of an ingredient refers to the amount of the raw material comprising the ingredient, wherein the raw material may be described herein to comprise less than and up to 100% activity of the ingredient. Therefore, weight percent of an active in a composition is represented as the amount of raw material containing the active that is used, and may or may not reflect the final percentage of the active, wherein the final percentage of the active is dependent on the weight percent of active in the raw material.
- weight percent and “wt%” may be used interchangeably and mean percent by weight, based on the total weight of a composition, article or material, except as may be specified with respect to, for example, a phase, or a system that is a component of a composition, article or material. All ranges and amounts given herein are intended to include subranges and amounts using any disclosed point as an end point. Thus, a range of "1% to 10%, such as 2% to 8%, such as 3% to 5%,” is intended to encompass ranges of "1% to 8%,” “1% to 5%,” “2% to 10%,” and so on. All numbers, amounts, ranges, etc., are intended to be modified by the term “about,” whether or not so expressly stated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23739023.2A EP4543395A1 (en) | 2022-06-21 | 2023-06-19 | Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/844,930 US12226506B2 (en) | 2022-06-21 | 2022-06-21 | Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds |
| US17/844,949 | 2022-06-21 | ||
| US17/844,930 | 2022-06-21 | ||
| US17/844,949 US20230404882A1 (en) | 2022-06-21 | 2022-06-21 | Composition comprising compound of thiopyridinone type and polyglyceryl-based emulsifiers |
| FR2211482 | 2022-11-04 | ||
| FR2211482A FR3141624B1 (en) | 2022-11-04 | 2022-11-04 | COMPOSITION COMPRISING A THIOPYRIDINONE-TYPE COMPOUND AND POLYGLYCERYL-BASED EMULSIFIERS |
| FR2211483A FR3141622B1 (en) | 2022-11-04 | 2022-11-04 | COSMETIC COMPOSITION COMPRISING NATURAL EMULSIFIERS AND THIOPYRIDINONE COMPOUNDS |
| FR2211483 | 2022-11-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023249915A1 true WO2023249915A1 (en) | 2023-12-28 |
Family
ID=87158418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2023/025681 Ceased WO2023249915A1 (en) | 2022-06-21 | 2023-06-19 | Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4543395A1 (en) |
| WO (1) | WO2023249915A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106074663A (en) * | 2016-08-24 | 2016-11-09 | 广州睿森生物科技有限公司 | One Plant Extracts and steroid-dependent dermatitis repair cream |
| EP3390363A1 (en) | 2015-12-18 | 2018-10-24 | L'oreal | Process for depigmenting keratin materials using thiopyridinone compounds |
| US20210401715A1 (en) * | 2020-06-30 | 2021-12-30 | L'oreal | Cosmetic composition for improved penetration |
| WO2022079122A1 (en) * | 2020-10-15 | 2022-04-21 | L'oreal | Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads |
-
2023
- 2023-06-19 WO PCT/US2023/025681 patent/WO2023249915A1/en not_active Ceased
- 2023-06-19 EP EP23739023.2A patent/EP4543395A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3390363A1 (en) | 2015-12-18 | 2018-10-24 | L'oreal | Process for depigmenting keratin materials using thiopyridinone compounds |
| CN106074663A (en) * | 2016-08-24 | 2016-11-09 | 广州睿森生物科技有限公司 | One Plant Extracts and steroid-dependent dermatitis repair cream |
| US20210401715A1 (en) * | 2020-06-30 | 2021-12-30 | L'oreal | Cosmetic composition for improved penetration |
| WO2022079122A1 (en) * | 2020-10-15 | 2022-04-21 | L'oreal | Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads |
Non-Patent Citations (2)
| Title |
|---|
| "Particle Size Analyzer ELSZ-2000", OTSUKA ELECTRONICS CO., LTD |
| J. PHARM. SCI., vol. 84, 1995, pages 83 - 92 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4543395A1 (en) | 2025-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6016728B2 (en) | Ceramide dispersion composition | |
| KR100873664B1 (en) | Hair restorer | |
| JP5453715B2 (en) | Hair nurturing agent and transdermal absorption enhancer | |
| JPH07316023A (en) | Hair tonic | |
| KR100917302B1 (en) | Ceramide emulsions | |
| JPWO2020067132A1 (en) | Topical composition containing ascorbic acid and / or a salt thereof | |
| JP2022526141A (en) | Plant peptides and their uses (II) | |
| MXPA04001137A (en) | Topical composition for follicular delivery of an ornithine decarboxylase inhibitor. | |
| EP4543395A1 (en) | Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds | |
| ES2257572T3 (en) | COSMETIC MICROEMULSIONS CONTAINING ECTOIN OR DERIVATIVES. | |
| US20230404882A1 (en) | Composition comprising compound of thiopyridinone type and polyglyceryl-based emulsifiers | |
| US12226506B2 (en) | Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds | |
| WO2023249912A1 (en) | Cosmetic composition comprising hydrophilic antioxidants and thiopyridinone compounds | |
| WO2020126732A1 (en) | Composition comprising a monoglyceride, a tartaric ester of monoglyceride and a salicylic acid compound | |
| JP2025519580A (en) | Solubilization of thiopyridinone compounds and compositions containing thiopyridinone compounds | |
| JP6702783B2 (en) | Skin penetration enhancer | |
| JP7479898B2 (en) | Transdermal absorption inhibitors | |
| FR3141622A1 (en) | COSMETIC COMPOSITION COMPRISING NATURAL EMULSIFIERS AND THIOPYRIDINONE COMPOUNDS | |
| FR3138310A1 (en) | STABILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING IT | |
| Seixas et al. | Antinociceptive activity of transdermal nanostructured surfactant-based systems containing duloxetine hydrochloride | |
| FR3141624A1 (en) | COMPOSITION COMPRISING A THIOPYRIDINONE-TYPE COMPOUND AND POLYGLYCERYL-BASED EMULSIFIERS | |
| WO2023245461A1 (en) | Composition for delivery of active compound | |
| WO2016102400A1 (en) | Composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound and a specific solvent | |
| JP2005002021A (en) | Skin preparation | |
| JP6719181B2 (en) | Skin cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23739023 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023739023 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2023739023 Country of ref document: EP Effective date: 20250121 |
|
| WWP | Wipo information: published in national office |
Ref document number: 2023739023 Country of ref document: EP |